News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
News
The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries. Trends & international news from global correspondents and breakthroughs in research in Coming Down the Pike.

Product planning groups integral to drive profitability

February 5, 2010

Pharmaceutical Technology Europe

A highly functioning New Product Planning (NPP) group is a company's first line of defence against losses caused by products that fail to reach the market, according to research and consulting firm Best Practices LLC.

Capsules enable on demand drug release

February 5, 2010

Pharmaceutical Technology Europe

Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing.

FDA Requests Another Major Budget Increase

February 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Less than a week after president Obama proposed a spending freeze on nonsecurity-related federal programs, the US Food and Drug Administration released its fiscal year 2011 budget request, calling for a 23% increase.

Pfizer Streamlines and Prioritizes Pipeline

February 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer's first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases.

AstraZeneca Announces Jobs Cuts and R&D Restructuring

February 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

AstraZeneca announced this week that it plans to undertake further restructuring in its research and development operations, resulting in the elimination of 3500 jobs.

FDA Issues Draft Guidance on Drugs with Potential for Abuse

February 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration issued a draft guidance for industry, Assessment of Abuse Potential of Drugs, in late January.

Senate Introduces Nanotechnology Safety Legislation

January 28, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a program within the US Food and Drug Administration to assess the health and safety implications of nanotechnology in everyday products.

WHO Denies Improper Pharmaceutical-Industry Influence on Pandemic Response

January 28, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Keiji Fukuda, special adviser on pandemic influenza to the World Health Organization's (WHO) director-general, told a hearing at the Council of Europe that WHO's response to the influenza (H1N1) pandemic was not improperly influenced by the pharmaceutical industry.

EMA outlines priorities for 2010–2015

January 28, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency has launched a public consultation on its Road Map to 2015, a strategic vision that lays out the agency's priorities for the next five years.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
40%
The US economic recovery
13%
Improved credit and financing flow to the small to emerging pharma/bio sector
15%
Less restrictive inventory control by pharmaceutical companies
8%
The level of competition from contract manufacturers in emerging markets
23%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Click here